about
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?Beta-catenin regulation during the cell cycle: implications in G2/M and apoptosisRAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway.SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells.In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis.Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5.Vesicular trafficking mechanisms in endothelial cells as modulators of the tumor vasculature and targets of antiangiogenic therapies.Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine.Hyaluronic acid/chitosan-g-poly(ethylene glycol) nanoparticles for gene therapy: an application for pDNA and siRNA delivery.Snai1 and Snai2 collaborate on tumor growth and metastasis properties of mouse skin carcinoma cell lines.Id-1 is induced in MDCK epithelial cells by activated Erk/MAPK pathway in response to expression of the Snail and E47 transcription factors.The nuclear corepressor 1 and the thyroid hormone receptor β suppress breast tumor lymphangiogenesis.Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth.Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1.Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system.A Cre-reporter transgenic mouse expressing the far-red fluorescent protein Katushka.UNR/CSDE1 Drives a Post-transcriptional Program to Promote Melanoma Invasion and Metastasis.Snail silencing effectively suppresses tumour growth and invasiveness.Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMTThe morphological and molecular features of the epithelial-to-mesenchymal transitionp62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors
P50
Q29547559-0D566F6F-5D85-4048-BA24-6175824659D1Q30478335-87F0D08D-DF44-49E4-8C09-5F565F969C5CQ34427215-72DFA5BB-CA75-4D23-9938-61FA21CAED50Q34727364-486710B9-AF6E-4A4E-BC87-7F337ECBB74BQ35924996-0F86D687-7F6D-4DF6-A318-C35A2983A18FQ37365473-CC72199D-8F94-4818-B2EC-383880AFD31AQ38600792-F025FA9F-7921-415F-87FA-33A1D252EFC0Q38704616-498CBEDD-D991-4124-B8DD-4BE649DA5580Q39653397-853E9843-F564-4865-A74C-A1E30673727EQ39992425-35D583F2-D675-4694-B909-B53D4CEE9619Q40134904-182B3E83-90B9-46F1-A26A-02375D9881D9Q42316995-3FC45B56-088B-4E1F-AA9E-05CB23684A77Q44225639-61369333-25C8-4C2C-9454-25B549514916Q47130336-B30030A6-484D-44D0-ACA7-F380C06CC6A8Q50526980-1956A092-B4EB-4645-902F-C77F4D7257AEQ50547997-7BEA7539-879D-49B4-85D6-A7A843FA1FACQ51291537-776FB8E6-DD4C-4F9A-A4EA-8AB68CE9B8AAQ54576035-7EB520A7-14F3-4CA7-9DB6-AA48BA99C252Q59123125-96D21E26-AD0C-44DF-880E-8915D5988024Q59123131-4ADAC8D0-8826-49C1-831C-FE4689B55B0DQ90727637-2BCEA371-7752-4265-8451-6CEB56EE3CD5
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David Olmeda
@ast
David Olmeda
@en
David Olmeda
@es
David Olmeda
@nl
David Olmeda
@sl
type
label
David Olmeda
@ast
David Olmeda
@en
David Olmeda
@es
David Olmeda
@nl
David Olmeda
@sl
altLabel
David Olmeda
@en
prefLabel
David Olmeda
@ast
David Olmeda
@en
David Olmeda
@es
David Olmeda
@nl
David Olmeda
@sl
P106
P21
P31
P496
0000-0001-5513-5621